Executive Medical Director, Rare Neuroendocrine & Metabolic Trials

Scorpion Therapeutics; Boston (MA); Hybrid; USD 300,000 - 420,000; Full time

Benefits offered by this job

Hybrid work in Boston

Up to 20% travel

Job summary

Scorpion Therapeutics seeks an Executive Medical Director to lead clinical development in rare neuroendocrine and metabolic diseases, guiding Phase 1–3 programs from design through regulatory submission. The role demands strategic medical leadership, cross-functional collaboration, and rigorous data interpretation in a fast-paced biotech environment.

Hybrid work in Boston with up to 20% travel; strong regulatory experience and a track record of global trial management are essential.

Qualifications

• MD degree with board certification in endocrinology, pediatrics, genetics or internal medicine.
• 8–10+ years in biopharma clinical development with global trial oversight.
• Strong knowledge of GCP, pharmacovigilance and rare diseases.

Responsibilities

• Serve as senior clinical leader and design clinical strategies.
• Develop and optimize protocols and trial designs.
• Provide medical oversight and safety leadership across programs.
• Manage global regulatory interactions and submissions.
• Interpret complex trial data and communicate findings.
• Mentor cross-functional teams and foster collaboration.
• Collaborate with external KOLs and contribute to scientific communication.

Skills

Clinical leadership

Strategic thinking

Cross-functional collaboration

Regulatory mindset

Education

MD degree

Board certification (Endocrinology / Pediatrics / Genetics / Internal Medicine)

Job description

Scorpion Therapeutics seeks an Executive Medical Director to lead clinical development in rare neuroendocrine and metabolic diseases, guiding Phase 1–3 programs from design through regulatory submission. The role demands strategic medical leadership, cross-functional collaboration, and rigorous data interpretation in a fast-paced biotech environment.

Hybrid work in Boston with up to 20% travel; strong regulatory experience and a track record of global trial management are essential.